Diagnostic FDG and FDOPA positron emission tomography scans distinguish the genomic type and treatment outcome of neuroblastoma

Yen Lin Liu, Meng Yao Lu, Hsiu Hao Chang, Ching Chu Lu, Dong Tsamn Lin, Shiann Tarng Jou, Yung Li Yang, Ya Ling Lee, Shiu Feng Huang, Yung Ming Jeng, Hsinyu Lee, James S. Miser, Kai Hsin Lin, Yung Feng Liao, Wen Ming Hsu, Kai Yuan Tzen

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Neuroblastoma (NB) is a heterogeneous childhood cancer that requires multiple imaging modalities for accurate staging and surveillances. This study aims to investigate the utility of positron emission tomography (PET) with 18F-fluorodeoxyglucose (FDG) and 18F-fluoro-dihydroxyphenylalanine (FDOPA) in determining the prognosis of NB. During 2007-2014, forty-two NB patients (male:female, 28:14; median age, 2.0 years) undergoing paired FDG and FDOPA PET scans at diagnosis were evaluated for the maximum standardized uptake value (SUVmax) of FDG or FDOPA by the primary tumor. Patients with older age, advanced stages, or MYCN amplification showed higher FDG and lower FDOPA SUVmax (all P < 0.02). Receiver operating characteristics analysis identified FDG SUVmax ≥ 3.31 and FDOPA SUVmax < 4.12 as an ultra-high-risk feature (PET-UHR) that distinguished the most unfavorable genomic types, i.e. segmental chromosomal alterations and/or MYCN amplification, at a sensitivity of 81.3% (54.4%-96.0%) and a specificity of 93.3% (68.1%-99.8%). Considering with age, stage, MYCN status, and anatomical image-defined risk factor, PET-UHR was an independent predictor of inferior event-free survival (multivariate hazard ratio, 4.9 [1.9-30.1]; P = 0.012). Meanwhile, the ratio between FDG and FDOPA SUVmax (G:D) correlated positively with HK2 (Spearman's ρ = 0.86, P < 0.0001) and negatively with DDC (ρ = -0.58, P = 0.02) gene expression levels, which might suggest higher glycolytic activity and less catecholaminergic differentiation in NB tumors taking up higher FDG and lower FDOPA. In conclusion, the intensity of FDG and FDOPA uptake on diagnostic PET scans may predict the tumor behavior and complement the current risk stratification systems of NB.

Original languageEnglish
Pages (from-to)18774-18786
Number of pages13
JournalOncotarget
Volume7
Issue number14
DOIs
Publication statusPublished - 2016

Fingerprint

Dihydroxyphenylalanine
Neuroblastoma
Positron-Emission Tomography
Neoplasms
Fluorodeoxyglucose F18
ROC Curve
Disease-Free Survival
Gene Expression

Keywords

  • Copy number alterations
  • FDG
  • FDOPA
  • Neuroblastoma
  • Positron emission tomography

ASJC Scopus subject areas

  • Oncology

Cite this

Diagnostic FDG and FDOPA positron emission tomography scans distinguish the genomic type and treatment outcome of neuroblastoma. / Liu, Yen Lin; Lu, Meng Yao; Chang, Hsiu Hao; Lu, Ching Chu; Lin, Dong Tsamn; Jou, Shiann Tarng; Yang, Yung Li; Lee, Ya Ling; Huang, Shiu Feng; Jeng, Yung Ming; Lee, Hsinyu; Miser, James S.; Lin, Kai Hsin; Liao, Yung Feng; Hsu, Wen Ming; Tzen, Kai Yuan.

In: Oncotarget, Vol. 7, No. 14, 2016, p. 18774-18786.

Research output: Contribution to journalArticle

Liu, YL, Lu, MY, Chang, HH, Lu, CC, Lin, DT, Jou, ST, Yang, YL, Lee, YL, Huang, SF, Jeng, YM, Lee, H, Miser, JS, Lin, KH, Liao, YF, Hsu, WM & Tzen, KY 2016, 'Diagnostic FDG and FDOPA positron emission tomography scans distinguish the genomic type and treatment outcome of neuroblastoma', Oncotarget, vol. 7, no. 14, pp. 18774-18786. https://doi.org/10.18632/oncotarget.7933
Liu, Yen Lin ; Lu, Meng Yao ; Chang, Hsiu Hao ; Lu, Ching Chu ; Lin, Dong Tsamn ; Jou, Shiann Tarng ; Yang, Yung Li ; Lee, Ya Ling ; Huang, Shiu Feng ; Jeng, Yung Ming ; Lee, Hsinyu ; Miser, James S. ; Lin, Kai Hsin ; Liao, Yung Feng ; Hsu, Wen Ming ; Tzen, Kai Yuan. / Diagnostic FDG and FDOPA positron emission tomography scans distinguish the genomic type and treatment outcome of neuroblastoma. In: Oncotarget. 2016 ; Vol. 7, No. 14. pp. 18774-18786.
@article{ed566f35f92347fc986bbc7c892aee32,
title = "Diagnostic FDG and FDOPA positron emission tomography scans distinguish the genomic type and treatment outcome of neuroblastoma",
abstract = "Neuroblastoma (NB) is a heterogeneous childhood cancer that requires multiple imaging modalities for accurate staging and surveillances. This study aims to investigate the utility of positron emission tomography (PET) with 18F-fluorodeoxyglucose (FDG) and 18F-fluoro-dihydroxyphenylalanine (FDOPA) in determining the prognosis of NB. During 2007-2014, forty-two NB patients (male:female, 28:14; median age, 2.0 years) undergoing paired FDG and FDOPA PET scans at diagnosis were evaluated for the maximum standardized uptake value (SUVmax) of FDG or FDOPA by the primary tumor. Patients with older age, advanced stages, or MYCN amplification showed higher FDG and lower FDOPA SUVmax (all P < 0.02). Receiver operating characteristics analysis identified FDG SUVmax ≥ 3.31 and FDOPA SUVmax < 4.12 as an ultra-high-risk feature (PET-UHR) that distinguished the most unfavorable genomic types, i.e. segmental chromosomal alterations and/or MYCN amplification, at a sensitivity of 81.3{\%} (54.4{\%}-96.0{\%}) and a specificity of 93.3{\%} (68.1{\%}-99.8{\%}). Considering with age, stage, MYCN status, and anatomical image-defined risk factor, PET-UHR was an independent predictor of inferior event-free survival (multivariate hazard ratio, 4.9 [1.9-30.1]; P = 0.012). Meanwhile, the ratio between FDG and FDOPA SUVmax (G:D) correlated positively with HK2 (Spearman's ρ = 0.86, P < 0.0001) and negatively with DDC (ρ = -0.58, P = 0.02) gene expression levels, which might suggest higher glycolytic activity and less catecholaminergic differentiation in NB tumors taking up higher FDG and lower FDOPA. In conclusion, the intensity of FDG and FDOPA uptake on diagnostic PET scans may predict the tumor behavior and complement the current risk stratification systems of NB.",
keywords = "Copy number alterations, FDG, FDOPA, Neuroblastoma, Positron emission tomography",
author = "Liu, {Yen Lin} and Lu, {Meng Yao} and Chang, {Hsiu Hao} and Lu, {Ching Chu} and Lin, {Dong Tsamn} and Jou, {Shiann Tarng} and Yang, {Yung Li} and Lee, {Ya Ling} and Huang, {Shiu Feng} and Jeng, {Yung Ming} and Hsinyu Lee and Miser, {James S.} and Lin, {Kai Hsin} and Liao, {Yung Feng} and Hsu, {Wen Ming} and Tzen, {Kai Yuan}",
year = "2016",
doi = "10.18632/oncotarget.7933",
language = "English",
volume = "7",
pages = "18774--18786",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals LLC",
number = "14",

}

TY - JOUR

T1 - Diagnostic FDG and FDOPA positron emission tomography scans distinguish the genomic type and treatment outcome of neuroblastoma

AU - Liu, Yen Lin

AU - Lu, Meng Yao

AU - Chang, Hsiu Hao

AU - Lu, Ching Chu

AU - Lin, Dong Tsamn

AU - Jou, Shiann Tarng

AU - Yang, Yung Li

AU - Lee, Ya Ling

AU - Huang, Shiu Feng

AU - Jeng, Yung Ming

AU - Lee, Hsinyu

AU - Miser, James S.

AU - Lin, Kai Hsin

AU - Liao, Yung Feng

AU - Hsu, Wen Ming

AU - Tzen, Kai Yuan

PY - 2016

Y1 - 2016

N2 - Neuroblastoma (NB) is a heterogeneous childhood cancer that requires multiple imaging modalities for accurate staging and surveillances. This study aims to investigate the utility of positron emission tomography (PET) with 18F-fluorodeoxyglucose (FDG) and 18F-fluoro-dihydroxyphenylalanine (FDOPA) in determining the prognosis of NB. During 2007-2014, forty-two NB patients (male:female, 28:14; median age, 2.0 years) undergoing paired FDG and FDOPA PET scans at diagnosis were evaluated for the maximum standardized uptake value (SUVmax) of FDG or FDOPA by the primary tumor. Patients with older age, advanced stages, or MYCN amplification showed higher FDG and lower FDOPA SUVmax (all P < 0.02). Receiver operating characteristics analysis identified FDG SUVmax ≥ 3.31 and FDOPA SUVmax < 4.12 as an ultra-high-risk feature (PET-UHR) that distinguished the most unfavorable genomic types, i.e. segmental chromosomal alterations and/or MYCN amplification, at a sensitivity of 81.3% (54.4%-96.0%) and a specificity of 93.3% (68.1%-99.8%). Considering with age, stage, MYCN status, and anatomical image-defined risk factor, PET-UHR was an independent predictor of inferior event-free survival (multivariate hazard ratio, 4.9 [1.9-30.1]; P = 0.012). Meanwhile, the ratio between FDG and FDOPA SUVmax (G:D) correlated positively with HK2 (Spearman's ρ = 0.86, P < 0.0001) and negatively with DDC (ρ = -0.58, P = 0.02) gene expression levels, which might suggest higher glycolytic activity and less catecholaminergic differentiation in NB tumors taking up higher FDG and lower FDOPA. In conclusion, the intensity of FDG and FDOPA uptake on diagnostic PET scans may predict the tumor behavior and complement the current risk stratification systems of NB.

AB - Neuroblastoma (NB) is a heterogeneous childhood cancer that requires multiple imaging modalities for accurate staging and surveillances. This study aims to investigate the utility of positron emission tomography (PET) with 18F-fluorodeoxyglucose (FDG) and 18F-fluoro-dihydroxyphenylalanine (FDOPA) in determining the prognosis of NB. During 2007-2014, forty-two NB patients (male:female, 28:14; median age, 2.0 years) undergoing paired FDG and FDOPA PET scans at diagnosis were evaluated for the maximum standardized uptake value (SUVmax) of FDG or FDOPA by the primary tumor. Patients with older age, advanced stages, or MYCN amplification showed higher FDG and lower FDOPA SUVmax (all P < 0.02). Receiver operating characteristics analysis identified FDG SUVmax ≥ 3.31 and FDOPA SUVmax < 4.12 as an ultra-high-risk feature (PET-UHR) that distinguished the most unfavorable genomic types, i.e. segmental chromosomal alterations and/or MYCN amplification, at a sensitivity of 81.3% (54.4%-96.0%) and a specificity of 93.3% (68.1%-99.8%). Considering with age, stage, MYCN status, and anatomical image-defined risk factor, PET-UHR was an independent predictor of inferior event-free survival (multivariate hazard ratio, 4.9 [1.9-30.1]; P = 0.012). Meanwhile, the ratio between FDG and FDOPA SUVmax (G:D) correlated positively with HK2 (Spearman's ρ = 0.86, P < 0.0001) and negatively with DDC (ρ = -0.58, P = 0.02) gene expression levels, which might suggest higher glycolytic activity and less catecholaminergic differentiation in NB tumors taking up higher FDG and lower FDOPA. In conclusion, the intensity of FDG and FDOPA uptake on diagnostic PET scans may predict the tumor behavior and complement the current risk stratification systems of NB.

KW - Copy number alterations

KW - FDG

KW - FDOPA

KW - Neuroblastoma

KW - Positron emission tomography

UR - http://www.scopus.com/inward/record.url?scp=84975495950&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84975495950&partnerID=8YFLogxK

U2 - 10.18632/oncotarget.7933

DO - 10.18632/oncotarget.7933

M3 - Article

VL - 7

SP - 18774

EP - 18786

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 14

ER -